A5031010156- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Ultrasound and Hyperthermia Applications
- Ultrasound in Clinical Applications
- Cardiac electrophysiology and arrhythmias
- Congenital Diaphragmatic Hernia Studies
- Neurological disorders and treatments
- Pain Management and Treatment
- Thermal Regulation in Medicine
- Pericarditis and Cardiac Tamponade
- Antiplatelet Therapy and Cardiovascular Diseases
- Pleural and Pulmonary Diseases
Medisch Spectrum Twente
2011-2021
Thorax Foundation
2021
Background: Left atrial appendage occlusion with WATCHMAN has emerged as viable alternative to vitamin K antagonists in randomized controlled trials. Evaluating real-life clinical outcomes fibrillation patients receiving the left closure technology was designed collect prospective multicenter of thromboembolic events, bleeding, and mortality for implanted a routine daily practice. Methods: One thousand twenty implant procedure were prospectively followed 47 centers. indication based on...
To evaluate the safety and effectiveness of pulmonary vein isolation in paroxysmal atrial fibrillation (PAF) using a standardized workflow aiming to enclose veins with contiguous optimized radiofrequency lesions.This multicentre, prospective, non-randomized study was conducted at 17 European sites. Pulmonary guided by VISITAG SURPOINT (VS target ≥550 on anterior wall; ≥400 posterior wall) intertag distance (≤6 mm). Atrial arrhythmia recurrence stringently monitored weekly symptom-driven...
Objective Pulmonary vein isolation (PVI) guided by a standardised CLOSE (contiguous optimised lesions) protocol has been shown to increase clinical success after catheter ablation for paroxysmal atrial fibrillation (PAF). This study analysed healthcare utilisation and quality of life (QOL) outcomes from large multicentre prospective study, measured association between QOL (AF) burden identified factors associated with lack improvement. Methods CLOSE-guided was performed in 329 consecutive...
Abstract Aims Pulmonary vein isolation (PVI) has become a cornerstone of the invasive treatment atrial fibrillation. Severe complications are reported in 1–3% patients. This study aims to compare and follow-up outcome PVI patients with Methods results The data were extracted from Netherlands Heart Registration. Procedural outcomes treated conventional radiofrequency (C-RF), multielectrode phased RF (Ph-RF), or cryoballoon (CB) ablation 2012 2017 compared. Subgroup analysis was performed...
Low oesophageal temperatures (OTs) during cryoballoon pulmonary vein isolation (PVI) have been associated with complications. This study assessed the incidence of low OT in clinical practice PVI and verified possible predictive values for OT.Consecutive patients who underwent using second-generation were retrospectively included. The distance from oesophagus to different veins (PVs) (OP distance), body mass index (BMI), sex, age, balloon temperature application time studied as potential...
Purpose: Atrial fibrillation (AF) is the most common supraventricular arrhythmia in patients with an implantable cardioverter defibrillator (ICD). We evaluated prognostic significance of AF ICD ischemic or dilated heart disease. Methods: 647 consecutive disease (81% male, mean age 64±10 years, 70% primary prevention) receiving Thoraxcenter Twente were included. Demographic data, including existence and type (permanent non-permanent) was collected. Primary endpoints all cause mortality...
dyspnoea or palpitations [1,[3][4][5].In symptomatic patients, percutaneous aspiration and ethanol sclerosis can be suggested, as well surgical resection [3,5].In asymptomatic no treatment is necessary [5].Annual observation optional performed by echocardiography, CT CMR.
Abstract Background/Introduction The use of a standardized ‘CLOSE’ ablation workflow for pulmonary vein isolation (PVI), with defined inter-tag distance (ITD) targeted index (AI) values, has been shown in single centre reports to result good outcomes. effect this approach on patients’ quality life (QoL) not studied. Purpose To evaluate the effects paroxysmal atrial fibrillation (PAF) by CLOSE QoL and symptomatic AF reduction multicenter VISTAX study. Methods 329 patients PAF (61.5% male,...
Abstract Background/Introduction The ‘CLOSE’ protocol, incorporating standardized ablation index (AI) targets in conjunction with defined inter-tag distance (ITD) has been shown to improve the acute and long-term success of pulmonary vein isolation (PVI) when treating paroxysmal atrial fibrillation (PAF). reproducibility learning curve for this protocol not studied. Purpose To assess efficacy CLOSE PVI across multiple operators (n = 37) 17-centre European study ‘VISTAX’. Methods 329 patients...